Sysmex : 【Conference presentation】Presenting the Most Recent Data at the 15th Clinical Trials on Alzheimer’s Disease:CTAD
November 24, 2022 at 07:14 pm EST
Share
Nov. 25, 2022
Sysmex Corporation will present the latest data on Alzheimer's Disease diagnostics using blood at "The 15th Clinical Trials on Alzheimer's Disease (CTAD) " to be held from November 29 to December 2, 2022 in San Francisco, California, United States.
Session
Subject
Presenter
(Affiliation)
Poster:
Clinical Trials:
Biomarkers including plasma
(LP84A*1)
Three group classification of participants based on fully automated plasma β-amyloid measurements to achieve high positive and negative predictive values.
Sysmex Corporation published this content on 25 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 November 2022 00:13:09 UTC.
Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.